Drugs / EE/NE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07446400 | Mar → Jun 2026 overdue | — | Otsuka Pharmaceutical Development & Commercialization, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EE/NE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07446400 ↗ |
| Route | Oral | “Oral tablet.” NCT07446400 ↗ |